Bone Biologics (BBLG) Accounts Payables (2016 - 2017)

Bone Biologics (BBLG) has disclosed Accounts Payables for 2 consecutive years, with $740064.0 as the latest value for Q3 2017.

  • On a quarterly basis, Accounts Payables rose 120.51% to $740064.0 in Q3 2017 year-over-year; TTM through Sep 2017 was $740064.0, a 120.51% increase, with the full-year FY2016 number at $226516.0, changed N/A from a year prior.
  • Accounts Payables was $740064.0 for Q3 2017 at Bone Biologics, up from $432330.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $740064.0 in Q3 2017 to a low of $159096.0 in Q1 2017.